Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes

Hdl Handle:
http://hdl.handle.net/10147/119159
Title:
Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes
Authors:
Tamagno, Gianluca; Celik, Yahya; Simo, Rafael; Dihne, Marcel; Kimura, Kazumi; Gelosa, Giorgio; Lee, Byung I.; Hommet, Caroline; Murialdo, Giovanni
Citation:
BMC Neurology. 2010 Apr 28;10(1):27
Issue Date:
28-Apr-2010
URI:
http://hdl.handle.net/10147/119159
Abstract:
Abstract Background The encephalopathy associated with autoimmune thyroid disease (EAATD) is characterized by neurological/psychiatric symptoms, high levels of anti-thyroid antibodies, increased cerebrospinal fluid protein concentration, non-specific electroencephalogram abnormalities, and responsiveness to the corticosteroid treatment in patients with an autoimmune thyroid disease. Almost all EAATD patients are affected by Hashimoto's thyroiditis (HT), although fourteen EAATD patients with Graves' disease (GD) have been also reported. Methods We have recorded and analyzed the clinical, biological, radiological, and electrophysiological findings and the data on the therapeutic management of all GD patients with EAATD reported so far as well as the clinical outcomes in those followed-up in the long term. Results Twelve of the fourteen patients with EAATD and GD were women. The majority of GD patients with EAATD presented with mild hyperthyroidism at EAATD onset or shortly before it. Active anti-thyroid autoimmunity was detected in all cases. Most of the patients dramatically responded to corticosteroids. The long term clinical outcome was benign but EAATD can relapse, especially at the time of corticosteroid dose tapering or withdrawal. GD and HT patients with EAATD present with a similar clinical, biological, radiological, and electrophysiological picture and require an unaffected EAATD management. Conclusions GD and HT equally represent the possible background condition for the development of EAATD, which should be considered in the differential diagnosis of all patients with encephalopathy of unknown origin and an autoimmune thyroid disease, regardless of the nature of the underlying autoimmune thyroid disease.
Item Type:
Journal Article

Full metadata record

DC FieldValue Language
dc.contributor.authorTamagno, Gianluca-
dc.contributor.authorCelik, Yahya-
dc.contributor.authorSimo, Rafael-
dc.contributor.authorDihne, Marcel-
dc.contributor.authorKimura, Kazumi-
dc.contributor.authorGelosa, Giorgio-
dc.contributor.authorLee, Byung I.-
dc.contributor.authorHommet, Caroline-
dc.contributor.authorMurialdo, Giovanni-
dc.date.accessioned2011-01-11T12:48:01Z-
dc.date.available2011-01-11T12:48:01Z-
dc.date.issued2010-04-28-
dc.identifierhttp://dx.doi.org/10.1186/1471-2377-10-27-
dc.identifier.citationBMC Neurology. 2010 Apr 28;10(1):27-
dc.identifier.urihttp://hdl.handle.net/10147/119159-
dc.description.abstractAbstract Background The encephalopathy associated with autoimmune thyroid disease (EAATD) is characterized by neurological/psychiatric symptoms, high levels of anti-thyroid antibodies, increased cerebrospinal fluid protein concentration, non-specific electroencephalogram abnormalities, and responsiveness to the corticosteroid treatment in patients with an autoimmune thyroid disease. Almost all EAATD patients are affected by Hashimoto's thyroiditis (HT), although fourteen EAATD patients with Graves' disease (GD) have been also reported. Methods We have recorded and analyzed the clinical, biological, radiological, and electrophysiological findings and the data on the therapeutic management of all GD patients with EAATD reported so far as well as the clinical outcomes in those followed-up in the long term. Results Twelve of the fourteen patients with EAATD and GD were women. The majority of GD patients with EAATD presented with mild hyperthyroidism at EAATD onset or shortly before it. Active anti-thyroid autoimmunity was detected in all cases. Most of the patients dramatically responded to corticosteroids. The long term clinical outcome was benign but EAATD can relapse, especially at the time of corticosteroid dose tapering or withdrawal. GD and HT patients with EAATD present with a similar clinical, biological, radiological, and electrophysiological picture and require an unaffected EAATD management. Conclusions GD and HT equally represent the possible background condition for the development of EAATD, which should be considered in the differential diagnosis of all patients with encephalopathy of unknown origin and an autoimmune thyroid disease, regardless of the nature of the underlying autoimmune thyroid disease.-
dc.titleEncephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes-
dc.typeJournal Article-
dc.language.rfc3066en-
dc.rights.holderTamagno et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2010-12-16T00:04:22Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.